The blockade of transient receptor potential ankyrin 1 (TRPA1) protects against PTZ-induced seizure
- 18 November 2022
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (2) , 621-630
Abstract
Treatment of epilepsy remains a major problem as some epileptic patients do not respond to the current therapeutics. Transient receptor potential ankyrin 1 (TRPA1) belongs to the TRP channels and has diverse physiological functions in the body. Considering its physiological properties, we aimed to evaluate its role in two experimental models of epilepsy, including pentylenetetrazol (PTZ)-induced acute seizure and PTZ-evoked kindling. Furthermore, the TRPA1 protein levels were assessed in the cerebral cortex, hippocampus, and cerebellum after seizure induction. Three groups of Wistar rats received acute intraperitoneal injection of pentylenetetrazol (PTZ, 85 mg/kg). The groups received intraventricular injections of vehicle (dimethyl sulfoxide, Tween 80, and sterile 0.9% saline), valproate (30 µg/rat), or HC030031 (TRPA1 antagonist, 14 µg/rat) before PTZ injection. In the PTZ-induced kindling model, PTZ was administrated 35 mg/kg every other day for 24 days. PTZ gradually provoked seizure-related behaviors. After experiments, the TRPA1 levels in the brain were assessed using western blot. The results showed that HC030031 reduced the median of seizure scores and S5 duration while increasing S2 and S5 latencies in acute and kindling models. The anticonvulsant effect of HC030031 was comparable with valproate as a standard anticonvulsant drug. Furthermore, induction of seizure, either acute or kindling, enhanced TRPA1 levels in the cerebral cortex, hippocampus, and cerebellum that were prevented by HC030031 or valproate administration. The results of this study showed that HC030031 as a TRPA1 receptor antagonist promoted a significant anticonvulsant effect comparable with valproate. Both drugs prevented TRPA1 upregulation during seizures. These findings imply that TRPA1 is a potential target in treating epilepsy.Keywords
Funding Information
- Mashhad University of Medical Sciences (931671)
This publication has 38 references indexed in Scilit:
- Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male ratsNeurological Sciences, 2014
- Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular MechanismsMolecular Pharmacology, 2013
- The Reverse Roles of Transient Receptor Potential Canonical Channel-3 and -6 in Neuronal Death Following Pilocarpine-Induced Status EpilepticusCellular and Molecular Neurobiology, 2012
- The functions of TRPA1 and TRPV1: moving away from sensory nervesBritish Journal of Pharmacology, 2012
- Allyl isothiocyanates and cinnamaldehyde potentiate miniature excitatory postsynaptic inputs in the supraoptic nucleus in ratsEuropean Journal of Pharmacology, 2011
- Astrocyte dysfunction in epilepsyBrain Research Reviews, 2010
- Molecular cloning and characterization of dog TRPA1 and AITC stimulate the gastrointestinal motility through TRPA1 in conscious dogsEuropean Journal of Pharmacology, 2009
- Transient receptor potential A1 increase glutamate release on brain stem neuronsNeuroReport, 2009
- Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysisJournal of Neurosurgery, 2004
- Animal Models Used in the Screening of Antiepileptic DrugsEpilepsia, 2001